Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


18.09.2017

3 Am J Pathol
9 Br J Dermatol
10 Cancer
3 Cancer Lett
6 Cancer Res
5 J Cutan Pathol
3 J Dermatol
25 J Invest Dermatol
5 Lancet Oncol
3 N Engl J Med
1 Ostomy Wound Manage
26 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. KISPERT S, Schwartz T, McHowat J
    Cigarette Smoke Regulates Calcium-Independent Phospholipase A2 Metabolic Pathways in Breast Cancer.
    Am J Pathol. 2017 Jun 12. pii: S0002-9440(17)30032.
    PubMed     Text format     Abstract available

  2. ZHANG J, Corciulo C, Liu H, Wilder T, et al
    Adenosine A2a Receptor Blockade Diminishes Wnt/beta-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.
    Am J Pathol. 2017;187:1935-1944.
    PubMed     Text format     Abstract available

  3. LAURIDSEN HM, Pellowe AS, Ramanathan A, Liu R, et al
    Tumor Necrosis Factor-alpha and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses.
    Am J Pathol. 2017;187:1893-1906.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. MOSSNER R, Wilsmann-Theis D, Oji V, Gkogkolou P, et al
    The genetic basis for most patients with pustular skin disease remains elusive.
    Br J Dermatol. 2017 Aug 5. doi: 10.1111/bjd.15867.
    PubMed     Text format     Abstract available

  5. EGEBERG A, Nast A
    The value and pitfalls of biologics registries for psoriasis.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15971.
    PubMed     Text format     Abstract available

  6. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available

  7. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available

  8. MAJEED-ARISS R, McPhee M, Bundy C, Griffiths CEM, et al
    Developing a protocol to identify and prioritise research questions for psoriasis: A James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15992.
    PubMed     Text format     Abstract available

  9. HOTZ A, Fagerberg C, Vahlquist A, Bygum A, et al
    Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994.
    PubMed     Text format     Abstract available

  10. HIETIKKO M, Hervonen K, Salmi T, Ilus T, et al
    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15995.
    PubMed     Text format     Abstract available

  11. NAGTZAAM IF, Peeters VPM, Vreeburg M, Wagner A, et al
    Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing-cholangitis syndrome without signs of liver disease.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15996.
    PubMed     Text format     Abstract available

  12. CHEE SN, Novakovic L, Fassihi H, Garibaldinos T, et al
    Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15969.
    PubMed     Text format     Abstract available


    Cancer

  13. HSU CD, Wang X, Habif DV Jr, Ma CX, et al
    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30722.
    PubMed     Text format     Abstract available

  14. KATZ SJ, Wallner LP, Abrahamse PH, Janz NK, et al
    Treatment experiences of Latinas after diagnosis of breast cancer.
    Cancer. 2017 Apr 11. doi: 10.1002/cncr.30702.
    PubMed     Text format     Abstract available

  15. LIANG X, Margolis KL, Hendryx M, Reeves K, et al
    Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30688.
    PubMed     Text format     Abstract available

  16. CASSIDY RJ, Liu Y, Kahn ST, Jegadeesh NK, et al
    The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30675.
    PubMed     Text format     Abstract available

  17. MASTELLARO MJ, Seidinger AL, Kang G, Abrahao R, et al
    Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
    Cancer. 2017;123:3150-3158.
    PubMed     Text format     Abstract available

  18. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
    County-level cumulative environmental quality associated with cancer incidence.
    Cancer. 2017;123:2901-2908.
    PubMed     Text format     Abstract available

  19. KOROUKIAN SM, Bakaki PM, Htoo PT, Han X, et al
    The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30720.
    PubMed     Text format     Abstract available

  20. MARMOR S, Hui JYC, Huang JL, Kizy S, et al
    Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Cancer. 2017;123:3015-3021.
    PubMed     Text format     Abstract available

  21. HENRY NL, Braun TM, Breslin TM, Gorski DH, et al
    Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
    Cancer. 2017 Mar 16. doi: 10.1002/cncr.30674.
    PubMed     Text format     Abstract available

  22. VAZ-LUIS I, O'Neill A, Sepucha K, Miller KD, et al
    Survival benefit needed to undergo chemotherapy: Patient and physician preferences.
    Cancer. 2017;123:2821-2828.
    PubMed     Text format     Abstract available


    Cancer Lett

  23. HALLDORSSON S, Rohatgi N, Magnusdottir M, Choudhary KS, et al
    Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
    Cancer Lett. 2017;396:117-129.
    PubMed     Text format     Abstract available

  24. DESHMUKH SK, Srivastava SK, Zubair H, Bhardwaj A, et al
    Resistin potentiates chemoresistance and stemness of breast cancer cells: implications for racially disparate therapeutic outcomes.
    Cancer Lett. 2017 Mar 13. pii: S0304-3835(17)30174.
    PubMed     Text format     Abstract available

  25. MONTEIRO FL, Vitorino R, Wang J, Cardoso H, et al
    The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells.
    Cancer Lett. 2017 Mar 10. pii: S0304-3835(17)30171.
    PubMed     Text format     Abstract available


    Cancer Res

  26. NDOYE A, Budina-Kolomets A, Kugel CH, Webster MR, et al
    ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma.
    Cancer Res. 2017 Sep 8. pii: canres.0907.2017.
    PubMed     Text format     Abstract available

  27. HANKER AB, Estrada MV, Bianchini G, Moore PD, et al
    Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer.
    Cancer Res. 2017 Apr 10. pii: canres.2808.2016.
    PubMed     Text format     Abstract available

  28. GAGGIANESI M, Turdo A, Chinnici A, Lipari E, et al
    IL-4 primes the dynamics of breast cancer progression via DUSP4 inhibition.
    Cancer Res. 2017 Apr 11. pii: canres.3126.2016.
    PubMed     Text format     Abstract available

  29. SAFONOV A, Jiang T, Bianchini G, Gyorffy B, et al
    Immune gene expression is associated with genomic aberrations in breast cancer.
    Cancer Res. 2017 Apr 20. pii: canres.3478.2016.
    PubMed     Text format     Abstract available

  30. VERHAEGEN ME, Mangelberger D, Harms PW, Eberl M, et al
    Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice.
    Cancer Res. 2017;77:3151-3157.
    PubMed     Text format     Abstract available

  31. ROSSI EL, Dunlap SM, Bowers LW, Khatib SA, et al
    Energy Balance Modulation Impacts Epigenetic Reprogramming, ERalpha and ERbeta Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice.
    Cancer Res. 2017;77:2500-2511.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  32. LEHMAN JS, Hashmi SK, Lazarus HM, El-Azhary RA, et al
    Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.
    J Cutan Pathol. 2017 Sep 14. doi: 10.1111/cup.13019.
    PubMed     Text format    

  33. DS E, Tb DG, Tp P, Nv P, et al
    Analysis of serum levels and cutaneous expression of Lipoprotein (a) in 38 patients with livedoid vasculopathy.
    J Cutan Pathol. 2017 Sep 13. doi: 10.1111/cup.13043.
    PubMed     Text format     Abstract available

  34. ROSA G, Fernandez AP, Schneider S, Billings SD, et al
    Eosinophils are rare in biopsy specimens of psoriasis vulgaris.
    J Cutan Pathol. 2017 Sep 13. doi: 10.1111/cup.13042.
    PubMed     Text format     Abstract available

  35. SUNDHARKRISHNAN L, North JP
    Histopathologic Features of Cutaneous Leishmaniasis and Use of CD1a Staining for Amastigotes in Old World and New World Leishmaniasis.
    J Cutan Pathol. 2017 Sep 11. doi: 10.1111/cup.13032.
    PubMed     Text format     Abstract available

  36. TETZLAFF MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, et al
    Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy. Report of two patients.
    J Cutan Pathol. 2017 Sep 13. doi: 10.1111/cup.13044.
    PubMed     Text format     Abstract available


    J Dermatol

  37. KIMURA R, Yoshida Y, Maruoka R, Kosaki K, et al
    Legius syndrome: A case report.
    J Dermatol. 2017;44:459-460.
    PubMed     Text format     Abstract available

  38. EHARA Y, Yamamoto O, Kosaki K, Yoshida Y, et al
    Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
    J Dermatol. 2017 Sep 11. doi: 10.1111/1346-8138.14025.
    PubMed     Text format     Abstract available

  39. MIYACHI H, Nakamura Y, Nakamura Y, Matsue H, et al
    Improvement of the initial stage of interstitial lung disease during psoriasis treatment with secukinumab.
    J Dermatol. 2017 Sep 11. doi: 10.1111/1346-8138.14026.
    PubMed     Text format    


    J Invest Dermatol

  40. OFENLOCH RF, Oosterhaven JAF, Susitaival P, Svensson A, et al
    Cross-Cultural Validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
    J Invest Dermatol. 2017;137:1454-1460.
    PubMed     Text format     Abstract available

  41. LAMBERT S, Swindell WR, Tsoi LC, Stoll SW, et al
    Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.
    J Invest Dermatol. 2017;137:1501-1511.
    PubMed     Text format     Abstract available

  42. SCHMIDT E, Spindler V, Eming R, Amagai M, et al
    Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.
    J Invest Dermatol. 2017;137:1199-1203.
    PubMed     Text format     Abstract available

  43. HUNT DW, Winters GC, Brownsey RW, Kulpa JE, et al
    Inhibition of Sebum Production with the Acetyl Coenzyme A Carboxylase Inhibitor Olumacostat Glasaretil.
    J Invest Dermatol. 2017;137:1415-1423.
    PubMed     Text format     Abstract available

  44. LIU Y, Peng L, Li L, Liu C, et al
    TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid.
    J Invest Dermatol. 2017;137:1512-1522.
    PubMed     Text format     Abstract available

  45. PANTAZI E, Gemenetzidis E, Teh MT, Reddy SV, et al
    GLI2 Is a Regulator of beta-Catenin and Is Associated with Loss of E-Cadherin, Cell Invasiveness, and Long-Term Epidermal Regeneration.
    J Invest Dermatol. 2017;137:1719-1730.
    PubMed     Text format     Abstract available

  46. DA SILVA LP, Santos TC, Rodrigues DB, Pirraco RP, et al
    Stem Cell-Laden Hyaluronic Acid-Based Spongy-Like Hydrogels for an Integrated Healing of Diabetic Wounds Pathophysiologies.
    J Invest Dermatol. 2017 Mar 1. pii: S0022-202X(17)31161.
    PubMed     Text format     Abstract available

  47. BLUNDER S, Koks S, Koks G, Reimann E, et al
    Enhanced expression of genes related to xenobiotic metabolism in the skin of patients with atopic dermatitis but not with ichthyosis vulgaris.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32936.
    PubMed     Text format     Abstract available

  48. WU CX, Liu ZF
    Proteomic profiling of sweat exosome suggests its involvement in skin immunity.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32931.
    PubMed     Text format     Abstract available

  49. KASPRICK A, Holtsche MM, Rose EL, Hussain S, et al
    The anti-C1s antibody TNT003 prevents complement activation in the skin induced by bullous pemphigoid autoantibodies.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32928.
    PubMed     Text format    

  50. THERENE C, Brenaut E, Barnetche T, Misery L, et al
    Efficacy of systemic treatments of psoriasis on pruritus: A systemic literature review and meta-analysis.
    J Invest Dermatol. 2017 Sep 5. pii: S0022-202X(17)32923.
    PubMed     Text format     Abstract available

  51. KAWAKAMI T, Okano T, Takeuchi S, Osumi K, et al
    New Approach for the Derivation of Melanocytes from Induced Pluripotent Stem (Ips) Cells.
    J Invest Dermatol. 2017 Sep 5. pii: S0022-202X(17)32921.
    PubMed     Text format     Abstract available

  52. YU B, Alboslemy T, Safadi F, Kim MH, et al
    Glycoprotein non-melanoma clone B regulates the crosstalk between macrophages and mesenchymal stem cells towards wound repair.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32934.
    PubMed     Text format     Abstract available

  53. HAO J, Xu H, Luo M, Yu W, et al
    The tumor-promoting role of TRIP4 in melanoma progression and its involvement in response to BRAF-targeted therapy.
    J Invest Dermatol. 2017 Sep 9. pii: S0022-202X(17)32937.
    PubMed     Text format     Abstract available

  54. ABUABARA K, Magyari AM, Hoffstad O, Jabbar-Lopez ZK, et al
    Development and Validation of an Algorithm to Accurately Identify Atopic Eczema Patients in Primary Care Electronic Health Records from the UK.
    J Invest Dermatol. 2017;137:1655-1662.
    PubMed     Text format     Abstract available

  55. MAKINO K, Makino T, Stawski L, Mantero JC, et al
    Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.
    J Invest Dermatol. 2017;137:1671-1681.
    PubMed     Text format     Abstract available

  56. WAKKEE M
    Smokers versus Smoking: Is There Detection Bias for Keratinocyte Carcinomas?
    J Invest Dermatol. 2017;137:1614-1616.
    PubMed     Text format     Abstract available

  57. MCBRIDE JD, Rodriguez-Menocal L, Badiavas EV
    Extracellular Vesicles as Biomarkers and Therapeutics in Dermatology: A Focus on Exosomes.
    J Invest Dermatol. 2017;137:1622-1629.
    PubMed     Text format     Abstract available

  58. BIRLEA SA
    S100B: Correlation with Active Vitiligo Depigmentation.
    J Invest Dermatol. 2017;137:1408-1410.
    PubMed     Text format     Abstract available

  59. MELNIK BC
    Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris.
    J Invest Dermatol. 2017;137:1405-1408.
    PubMed     Text format     Abstract available

  60. HAPPLE R
    Becker's Nevus and Lethal Beta-Actin Mutations.
    J Invest Dermatol. 2017;137:1619-1621.
    PubMed     Text format     Abstract available

  61. MATOS TR, de Rie MA, Teunissen MBM
    Research Techniques Made Simple: High-Throughput Sequencing of the T-Cell Receptor.
    J Invest Dermatol. 2017;137:e131-e138.
    PubMed     Text format     Abstract available

  62. MEYSKENS FL JR, Liu-Smith F
    Redox-Redux and NADPH Oxidase (NOX): Even More Complicated than We Thought it Might Be.
    J Invest Dermatol. 2017;137:1208-1210.
    PubMed     Text format     Abstract available

  63. HEPPE EN, Tofern S, Schulze FS, Ishiko A, et al
    Experimental Laminin 332 Mucous Membrane Pemphigoid Critically Involves C5aR1 and Reflects Clinical and Immunopathological Characteristics of the Human Disease.
    J Invest Dermatol. 2017;137:1709-1718.
    PubMed     Text format     Abstract available

  64. O'BRIEN JC, Rainwater YB, Malviya N, Cyrus N, et al
    Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.
    J Invest Dermatol. 2017;137:1663-1670.
    PubMed     Text format     Abstract available


    Lancet Oncol

  65. STEBBING J, Baranau Y, Baryash V, Manikhas A, et al
    CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
    Lancet Oncol. 2017 Jun 2. pii: S1470-2045(17)30434.
    PubMed     Text format     Abstract available

  66. DEL PAGGIO JC, Sullivan R, Schrag D, Hopman WM, et al
    Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.
    Lancet Oncol. 2017;18:887-894.
    PubMed     Text format     Abstract available

  67. BASELGA J, Im SA, Iwata H, Cortes J, et al
    Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2017 May 30. pii: S1470-2045(17)30376.
    PubMed     Text format     Abstract available

  68. ALLGOOD PC, Maroni R, Hudson S, Offman J, et al
    Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.
    Lancet Oncol. 2017 May 15. pii: S1470-2045(17)30340.
    PubMed     Text format     Abstract available

  69. CAMERON D, Morden JP, Canney P, Velikova G, et al
    Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, co
    Lancet Oncol. 2017 Jun 6. pii: S1470-2045(17)30404.
    PubMed     Text format     Abstract available


    N Engl J Med

  70. WOLCHOK JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.
    PubMed     Text format     Abstract available

  71. LONG GV, Hauschild A, Santinami M, Atkinson V, et al
    Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1708539.
    PubMed     Text format     Abstract available

  72. WEBER J, Mandala M, Del Vecchio M, Gogas HJ, et al
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.
    PubMed     Text format     Abstract available


    Ostomy Wound Manage

  73. SCHEINER J, Farid K, Raden M, Demisse S, et al
    Ultrasound to Detect Pressure-related Deep Tissue Injuries in Adults Admitted via the Emergency Department: A Prospective, Descriptive, Pilot Study.
    Ostomy Wound Manage. 2017;63:36-46.
    PubMed     Text format     Abstract available


    PLoS One

  74. SMITH-STROM H, Iversen MM, Igland J, Ostbye T, et al
    Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: A retrospective cohort study.
    PLoS One. 2017;12:e0177176.
    PubMed     Text format     Abstract available

  75. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available

  76. OKUBO Y, Masuyama R, Iwanaga A, Koike Y, et al
    Calcification in dermal fibroblasts from a patient with GGCX syndrome accompanied by upregulation of osteogenic molecules.
    PLoS One. 2017;12:e0177375.
    PubMed     Text format     Abstract available

  77. CHANDA A, Chan A, Deng L, Kornaga EN, et al
    Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.
    PLoS One. 2017;12:e0177639.
    PubMed     Text format     Abstract available

  78. NISKANEN J, Dillard K, Arumilli M, Salmela E, et al
    Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs.
    PLoS One. 2017;12:e0177527.
    PubMed     Text format     Abstract available

  79. SUNG W, Park JI, Kim JI, Carlson J, et al
    Monte Carlo simulation for scanning technique with scattering foil free electron beam: A proof of concept study.
    PLoS One. 2017;12:e0177380.
    PubMed     Text format     Abstract available

  80. COLLINS D, Jacob W, Cejalvo JM, Ceppi M, et al
    Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.
    PLoS One. 2017;12:e0177331.
    PubMed     Text format     Abstract available

  81. GILBERT PB, Excler JL, Tomaras GD, Carpp LN, et al
    Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
    PLoS One. 2017;12:e0176428.
    PubMed     Text format     Abstract available

  82. HULTGREN EM, Patrick ME, Evans RL, Stoos CT, et al
    SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
    PLoS One. 2017;12:e0177089.
    PubMed     Text format     Abstract available

  83. LI Y, Su J, Li F, Chen X, et al
    MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1alpha and VEGFA: Implications for psoriasis treatment.
    PLoS One. 2017;12:e0175459.
    PubMed     Text format     Abstract available

  84. ZHAO M, Howard EW, Guo Z, Parris AB, et al
    p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells.
    PLoS One. 2017;12:e0175121.
    PubMed     Text format     Abstract available

  85. FANG S, Tian H, Li X, Jin D, et al
    Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.
    PLoS One. 2017;12:e0175050.
    PubMed     Text format     Abstract available

  86. SCHMITZ AMT, Teixeira SC, Pengel KE, Loo CE, et al
    Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
    PLoS One. 2017;12:e0176782.
    PubMed     Text format     Abstract available

  87. BAQIR M, Makol A, Osborn TG, Bartholmai BJ, et al
    Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.
    PLoS One. 2017;12:e0177107.
    PubMed     Text format     Abstract available

  88. KISIEL B, Kisiel K, Szymanski K, Mackiewicz W, et al
    The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci.
    PLoS One. 2017;12:e0179348.
    PubMed     Text format     Abstract available

  89. BAI A, Mao C, Jenkins RW, Szulc ZM, et al
    Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase.
    PLoS One. 2017;12:e0177805.
    PubMed     Text format     Abstract available

  90. PENICHE AG, Bonilla DL, Palma GI, Melby PC, et al
    A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis.
    PLoS One. 2017;12:e0179084.
    PubMed     Text format     Abstract available

  91. HAYES DA, Kunde DA, Taylor RL, Pyecroft SB, et al
    ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
    PLoS One. 2017;12:e0177919.
    PubMed     Text format     Abstract available

  92. JAEGER BAS, Neugebauer J, Andergassen U, Melcher C, et al
    The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.
    PLoS One. 2017;12:e0173593.
    PubMed     Text format     Abstract available

  93. GODLEWSKA M, Arczewska KD, Rudzinska M, Lyczkowska A, et al
    Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties.
    PLoS One. 2017;12:e0179066.
    PubMed     Text format     Abstract available

  94. MISHRA AK, Parish CR, Wong ML, Licinio J, et al
    Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.
    PLoS One. 2017;12:e0178454.
    PubMed     Text format     Abstract available

  95. YU GM, Kubota H, Okita M, Maeda T, et al
    The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells.
    PLoS One. 2017;12:e0178525.
    PubMed     Text format     Abstract available

  96. KOSTER B, Sondergaard J, Nielsen JB, Christensen KB, et al
    Knowledge deficit, attitude and behavior scales association to objective measures of sun exposure and sunburn in a Danish population based sample.
    PLoS One. 2017;12:e0178190.
    PubMed     Text format     Abstract available

  97. EVERS C, Fischer C, Dikow N, Schott S, et al
    Familial breast cancer: Genetic counseling over time, including patients expectations and initiators considering the Angelina Jolie effect.
    PLoS One. 2017;12:e0177893.
    PubMed     Text format     Abstract available

  98. CHOI Y, Kim SH, Youn IK, Kang BJ, et al
    Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype.
    PLoS One. 2017;12:e0177903.
    PubMed     Text format     Abstract available

  99. BLOCH-INFANGER C, Battig V, Kremo J, Widmer AF, et al
    Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland.
    PLoS One. 2017;12:e0179537.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: